Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GKOS
#1101
Glaukos Corporation
121.0
1
USD
+0.38%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.38%
Monthly Change
+21.95%
6 month change
+42.01%
Year Change
+35.80%
Previous Close
120.5
5
Open
119.9
6
Bid
Ask
Low
119.7
2
High
121.1
0
Volume
363
Markets
US Stock Market
Healthcare
GKOS
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
56.57 M
57.14 M
57.35 M
57.43 M
58.08 M
—
Valuation ratios
Enterprise value
8.31 B
5.51 B
5.82 B
4.59 B
6.47 B
22.38 B
Price to earnings ratio
-54.13
-43.36
-64.16
-54.37
-34.42
-196.3
Price to sales ratio
20.63
13.08
13.23
9.73
12.73
48.76
Price to cash flow ratio
-129
-115.28
-279.48
-219.7
-436.63
-1 051.09
Price to book ratio
10.31
1.85
1.93
1.49
9.84
15.1
Enterprise value to EBITDA ratio
-95.85
-109.5
-117.2
-85.35
-132.95
-445
Profitability ratios
Return on assets %
-0.03
-0.02
-0.02
-0.02
-0.15
-0.2
Return on equity %
-0.04
-0.02
-0.03
-0.02
-0.2
-0.27
Return on invested capital %
-15.39
-11.13
-11.56
-8.2
-70.6
-101.49
Gross margin %
72.86
77.2
78.33
78.41
-1.06
232.88
Operating margin %
-27.17
-19.39
-18.28
-12.26
-97.73
-147.65
EBITDA margin %
-18.89
-11.67
-11.38
-5.42
-10.37
-38.83
Net margin %
-31.83
-17.01
-15.84
-12.15
-93.39
-138.39
Liquidity ratios
Quick ratio
5.22
5.62
4.69
4.47
4.06
18.84
Current ratio
5.99
6.49
5.51
5.2
4.69
21.88
Inventory turnover
0.49
0.42
0.43
0.45
0.5
1.8
Asset turnover
0.11
0.11
0.13
0.13
0.15
0.52
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.01
-0.33
0.12
-0.18
0.12
-0.26
EBIT per share
-0.54
-0.37
-0.4
-0.29
-0.47
-1.52
EBITDA per share
-0.38
-0.22
-0.25
-0.13
-0.26
-0.85
Total debt per share
—
—
—
—
—
—
Cash per share
3.22
2.02
1.76
1.71
1.59
7.08
Net current asset value per share
8.53
7.85
7.62
7.92
8.31
31.7
Tangible book value per share
8.29
7.77
7.48
7.64
7.83
30.72
Working capital per share
7.1
6.64
6.24
6.4
6.53
25.81
Book value per share
14.54
13.49
13.37
13.41
11.47
51.74
News
Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments
Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?
Stifel reiterates Glaukos stock rating on product momentum
Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook
Needham raises Glaukos stock price target on iDose, Epioxa growth
These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Glaukos (NYSE:GKOS)
Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript
Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say
Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates
Glaukos earnings on deck as iDose, Epioxa launches converge
Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth
Stifel reiterates Buy rating on Glaukos stock with $160 price target